
Teladoc (TDOC) Stock Forecast & Price Target
Teladoc (TDOC) Analyst Ratings
Bulls say
Teladoc Health is projected to see slower growth in the BetterHelp segment and a potential decrease in membership, leading to a reduction in revenue. Despite this, their integrated care segment shows promise, and the company has been investing in AI technology, which could lead to long-term success. With their current valuation and solid cost management, there is potential for upward momentum, but the company needs to show stability across all segments for this to occur.
Bears say
Teladoc Health is facing challenges in its transition from a stable, fee-based subscription revenue model to a more volatile visit-based model, leading to uncertainty and a decrease in projected membership. Despite this, Teladoc's virtual care platform and expansion into mental health, chronic care management, and virtual primary care offer long-term growth opportunities. However, these initiatives also require significant investments and there is a risk of pricing pressure and increased competition in the market. To meet its projected revenues and profitability, Teladoc will need to add approximately $36.4M in Integrated Care adjusted EBITDA in CY26, which may require a reduction in stock-based compensation and an increase in tariffs.
This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.
Teladoc (TDOC) Analyst Forecast & Price Prediction
Start investing in Teladoc (TDOC)
Order type
Buy in
Order amount
Est. shares
0 shares